Imaging Biometrics Ltd. (LON:IBAI)
0.5350
+0.0350 (7.00%)
At close: Feb 12, 2026
Imaging Biometrics Market Cap
Imaging Biometrics has a market cap or net worth of 1.32 million as of February 12, 2026. Its market cap has decreased by -63.92% in one year.
Market Cap
1.32M
Enterprise Value
1.25M
Revenue
699.86K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
Market Cap Chart
Since June 16, 2017, Imaging Biometrics's market cap has decreased from 2.14M to 1.32M, a decrease of -38.21%. That is a compound annual growth rate of -5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.23M | -41.18% |
| Dec 31, 2025 | 2.10M | -32.44% |
| Dec 31, 2024 | 3.10M | -65.36% |
| Dec 29, 2023 | 8.96M | 168.89% |
| Dec 30, 2022 | 3.33M | -69.56% |
| Dec 31, 2021 | 10.95M | -37.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Chill Brands Group | 2.75M |
| BSF Enterprise | 2.57M |
| ValiRx | 2.45M |
| Roquefort Therapeutics | 1.80M |